Serum alpha‐fetoprotein level independently predicts posttransplant survival in patients with hepatocellular carcinoma
Kristin Berry, George N. Ioannou – 27 March 2013 – We aimed to determine whether combining serum alpha‐fetoprotein (AFP) level with hepatocellular carcinoma (HCC) tumor burden would allow better stratification of posttransplant survival for patients with HCC undergoing liver transplantation. Adjusting for donor and recipient characteristics, we calculated the risk of posttransplant mortality associated with serum AFP level or HCC tumor burden for all first‐time adult liver transplants performed in the United States between 2002 and 2011 (n = 45,267).